Michael E. Paolucci
Known title: DirectorCIK: 0001599463
Michael E. Paolucci's purchase track record
Michael E. Paolucci has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/22/2021 | OFIX | $62K | -3.6% | -16.0% | -15.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OFIX | ▲ Buy | Grant | 14,965 | $0 | 6/10/2026 | View on chart |
| OFIX | ▲ Buy | Grant | 18,841 | $0 | 6/18/2025 | View on chart |
| OFIX | ▲ Buy | Grant | 15,152 | $195K | 6/18/2024 | View on chart |
| OFIX | ▲ Buy | Grant | 14,052 | $0 | 1/5/2023 | View on chart |
| OFIX | ▲ Buy | Grant | 6,383 | $0 | 6/6/2022 | View on chart |
| OFIX | ▲ Buy | Open Market | 2,000 | $62K | 11/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Orthofix pays $24M in damages to former executives
Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.
Orthofix pays $24M in damages to former executives. Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.